Atria Investments buys $2,504,575 stake in Dow Chemical Co (DOW)

Dow Chemical Co (DOW) : Atria Investments scooped up 7,883 additional shares in Dow Chemical Co during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 12, 2016. The investment management firm now holds a total of 46,797 shares of Dow Chemical Co which is valued at $2,504,575.Dow Chemical Co makes up approximately 0.23% of Atria Investments’s portfolio.

Other Hedge Funds, Including , Daiwa Sb Investments Ltd. reduced its stake in DOW by selling 15,010 shares or 63.47% in the most recent quarter. The Hedge Fund company now holds 8,640 shares of DOW which is valued at $462,413. Dow Chemical Co makes up approx 0.12% of Daiwa Sb Investments Ltd.’s portfolio.Salem Capital Management Inc boosted its stake in DOW in the latest quarter, The investment management firm added 1,525 additional shares and now holds a total of 113,600 shares of Dow Chemical Co which is valued at $6,082,144. Dow Chemical Co makes up approx 3.36% of Salem Capital Management Inc’s portfolio.Central Bank Trust Co reduced its stake in DOW by selling 41 shares or 4.51% in the most recent quarter. The Hedge Fund company now holds 869 shares of DOW which is valued at $46,048. Dow Chemical Co makes up approx 0.01% of Central Bank Trust Co’s portfolio.Lynch Associatesin boosted its stake in DOW in the latest quarter, The investment management firm added 1,460 additional shares and now holds a total of 64,497 shares of Dow Chemical Co which is valued at $3,398,992. Dow Chemical Co makes up approx 1.50% of Lynch Associatesin’s portfolio.Eqis Capital Management boosted its stake in DOW in the latest quarter, The investment management firm added 5,233 additional shares and now holds a total of 22,814 shares of Dow Chemical Co which is valued at $1,202,298. Dow Chemical Co makes up approx 0.08% of Eqis Capital Management’s portfolio.

Dow Chemical Co closed down -0.02 points or -0.04% at $53.52 with 49,63,840 shares getting traded on Tuesday. Post opening the session at $53.44, the shares hit an intraday low of $52.92 and an intraday high of $53.53 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Dow Chemical Co reported $0.95 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.86. The company had revenue of $11952.00 million for the quarter, compared to analysts expectations of $11226.05 million. The company’s revenue was down -7.4 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.91 EPS.

Many Wall Street Analysts have commented on Dow Chemical Co. Company shares were Upgraded by UBS on Oct 10, 2016 to ” Buy”, Firm has raised the Price Target to $ 62 from a previous price target of $53 .Dow Chemical Co was Upgraded by Citigroup to ” Buy” on Oct 3, 2016. Dow Chemical Co was Upgraded by JP Morgan to ” Overweight” on Jul 29, 2016.

The Dow Chemical Company (Dow) is as an integrated science and technology company. The Company is a diversified manufacturer and supplier of products used primarily as raw materials in the manufacture of customer products and services across the world. The Company operates in five segments: Agricultural Sciences Consumer Solutions Infrastructure Solutions Performance Materials & Chemicals and Performance Plastics. The Company serves various industries such as appliance automotive agricultural building and construction chemical processing electronics furniture housewares oil and gas packaging paints coatings and adhesives personal care pharmaceutical processed foods pulp and paper textile and carpet utilities and water treatment.

Leave a Reply

Dow Chemical Co - Is it time to Sell?

Top Brokerage Firms are advising their investors on Dow Chemical Co. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.